Investing
HAMVX Q3 2025: 8.96% Return Beats Benchmark
Navigating Crosscurrents in Risk Assets Markets
Nebius Group Stock: Path to 10x Portfolio Growth
Latest Posts
Jack Bogle’s Easy Portfolio Adjustment for Over-50 Investors
Investing does not demand poring over corporate earnings statements or expert forecasts to pinpoint the next big stock winners. Actually,
LVS Advisory Q4 2025 Investor Letter: Performance Review
Dear Investors Throughout the entire year of 2025, the LVS Event-Driven Portfolio delivered a solid return of 9.1%, while the
Is It Time to Sell Your Affirm Stock Holdings?
Affirm, a prominent consumer credit firm listed on the NYSE under the ticker AFRM, derives a substantial portion of its
Celestica’s Scaling Strategy Powers AI Growth
Summary Celestica continues to shine as a premier provider of essential components in the AI infrastructure sector, distinguished by its
John Hancock 2040 Lifetime Blend Q4 2025 Review
Quarterly Performance Overview During the final quarter of 2025, the majority of asset classes within the portfolio delivered strong performance,
Tech Giants’ Massive $650B AI Investment Surge
Major technology companies are pouring enormous sums into their operations, sparking a mix of excitement and apprehension regarding the scale
S&P Global: Undervalued Dividend Aristocrat for Long-Term Portfolios
S&P Global Inc. (SPGI) stands as a premier American company delivering essential credit ratings, benchmarks, analytics, and workflow solutions across
Entergy’s Earnings Foundation Keeps Climbing Higher
Despite ongoing increases in its share price, I maintain my Buy recommendation for Entergy Corporation. This stance is supported by
Berkshire Hathaway Buys NYT Shares: Buy Now?
Berkshire Hathaway Establishes Position in The New York Times Renowned investment conglomerate Berkshire Hathaway, led by legendary investor Warren Buffett,
More Articles
Is It Time to Sell Your Affirm Stock Holdings?
Affirm, a prominent consumer credit firm listed on the NYSE under the ticker AFRM, derives a substantial portion of its
AI Boom: Real Transformation with Rational Exuberance Risks
Comparing the AI Surge to the Dotcom Era Andrew Van Sickle: A prominent recurring topic this year, which also features
Ark Invest’s Forecast Signals Challenges for Rigetti Quantum Stock
Rigetti Computing Faces Headwinds from Ark Invest’s Quantum Outlook In 2025, investors showed tremendous enthusiasm for quantum computing stocks, driving
Jill Scott’s Path: From Pitch to Smart Portfolio Building
Former England Lioness Jill Scott opens up about her personal investing journey and explains her strategic approach to achieving long-term
LVS Advisory Q4 2025 Investor Letter: Performance Review
Dear Investors Throughout the entire year of 2025, the LVS Event-Driven Portfolio delivered a solid return of 9.1%, while the
Top 3 Stocks Thriving in AI Boom and Future Growth
Equity markets worldwide are showing signs of increased vulnerability, with a heavy reliance on the United States, which itself is
Avoid Costly RMD Errors in Retirement Planning
Choosing the Right Retirement Savings Vehicle During the accumulation phase of your retirement savings journey, selecting the appropriate account type
2 Overlooked AI Stocks Poised for 112% and 196% Gains, Per Wall Street
Key Insights Numerous Wall Street analysts anticipate significant growth potential for The Trade Desk and Datadog, with the broad consensus
CoreWeave Stock Up 30% in 2026: AI Infrastructure Boom Ahead
CoreWeave’s Impressive Rise in the AI Sector CoreWeave, trading under the ticker CRWV, has experienced a remarkable beginning to 2026,
Entergy’s Earnings Foundation Keeps Climbing Higher
Despite ongoing increases in its share price, I maintain my Buy recommendation for Entergy Corporation. This stance is supported by
Fidelity Real Estate Income Fund Q4 2025 Review
Performance Summary During the fourth quarter of 2025, the Retail Class shares of the Fidelity Real Estate Income Fund achieved
Organigram Boosts Revenue and Net Income in Q1-2026
Organigram Delivers Strong Q1-2026 Financial Performance Organigram Global Inc. (NASDAQ: OGI) has recently announced its financial results for the first